Achilles Tendinopathy

Clinical Research Hub: Regenerative Energy and Injectable Evidence for Achilles Tendinopathy

Within our proprietary 10R™ Treatment Philosophy, conservative management of chronic Achilles tendinopathy is structured under Reduce & Regenerate:

• Reduce and Rehabilitate: Primary focus is placed on controlling acute mechanical strain and localized inflammation through activity modification, heel lifts, functional orthoses, and progressive loading protocols.
  
• Regenerate (Recharge, Reset, Recruit):
  
  • Recharge (Laser / Photobiomodulation): Dual-wavelength laser emissions are thought to stimulate mitochondrial cytochrome c oxidase activity and cellular ATP synthesis.
    
  • Reset (EMTT): Extracorporeal Magnetotransduction Therapy is designed to influence cell membrane ion channels and biophysical signaling in connective tissue.
    
  • Recruit (ESWT & Orthobiologics): Extracorporeal shockwave therapy and targeted injections (such as hypertonic dextrose prolotherapy or amniotic tissue particulate) are intended to stimulate microvascular growth factors and support collagen matrix remodeling.

Progressive physical rehabilitation—specifically heavy slow resistance and eccentric calf-loading exercise—combined with biomechanical offloading forms the evidence-based foundation of non-surgical Achilles care.

Advanced acoustic shockwave (ESWT), magnetic fields (EMTT), laser photobiomodulation, and targeted injections serve as optional, non-surgical adjuncts intended to support tendon recovery when foundational measures are insufficient.

Executive Summary (TL;DR)

Progressive loading remains the foundational standard of care; Clinical research indicates that chronic midportion and insertional Achilles tendinopathy responds favorably to structured non-surgical care.

High-level evidence (Level 1b RCTs) demonstrates that adding Extracorporeal Shockwave Therapy (ESWT) to eccentric loading achieves an 82% success rate in midportion tendinopathy and a 64% success rate in insertional cases.

Combining focused and radial shockwaves provides up to an 89.7% functional success rate on VISA-A scoring.

Laser photobiomodulation paired with eccentric loading significantly reduces activity pain versus exercise alone.

Conversely, Level 1a meta-analyses and Level 1b RCTs demonstrate that autologous Platelet-Rich Plasma (PRP) does not outperform placebo or sham injections for Achilles tendinopathy.

Key Clinical Takeaways

• 🔵 Eccentric Loading + Radial ESWT: Demonstrated in Level 1b clinical trials to achieve an 82% success rate (VISA-A functional gain) at 4 months in midportion Achilles tendinopathy compared to 60% with eccentric exercise alone (p = 0.002) (J.D. Rompe et al., AJSM, 2009) [Level 1b / Grade A | SDM: A].
  
• 🔵 Insertional Radial ESWT: Clinically proven in Level 1b randomized trials to achieve a 64% success rate in insertional Achilles pain at 4 months, outperforming eccentric training (28%) and wait-and-see management (24%) (p < 0.001) (J.D. Rompe et al., JBJS, 2008) [Level 1b / Grade A | SDM: A].
  
• 🟢 Combined Focused + Radial ESWT: Shown in Level 2 clinical research to achieve an 89.7% MCID functional success rate on VISA-A scores versus 63.8% for radial shockwave alone (p = 0.022) (David M. Robinson et al., JFAS, 2021) [Level 2 / Grade B | SDM: B].
  
• 🔵 Laser Photobiomodulation + Eccentric Exercise: Demonstrated in Level 1b randomized trials to significantly reduce activity-related Achilles pain (33 mm vs. 53 mm VAS at 12 weeks, p = 0.007) when paired with progressive loading (Stergioulas et al., AJSM, 2008) [Level 1b / Grade A | SDM: B].
  
• 🔵 🛑 Autologous PRP Ineffective in Achilles: Clinically proven in Level 1a meta-analyses and Level 1b multicenter RCTs to provide no significant VISA-A functional or pain benefit over sham or placebo injections at 3, 6, or 12 months (Kearney RS et al., JAMA, 2021) [Level 1b / Grade A | SDM: D].

Biological Mechanism of Action

• Extracorporeal Shockwave Therapy (ESWT – Focused & Radial): Acoustic energy pulses and pressure waves are thought to deliver localized micro-mechanical stress to degenerate tendon tissue, which is believed to stimulate vascular endothelial growth factor (VEGF) expression, increase microvascular blood flow, and modulate nociceptive substance P transmission in chronic tendinopathy.
  
• Extracorporeal Magnetotransduction Therapy (EMTT): High-frequency magnetic field oscillations (~80 mT) are designed to penetrate deep tendon structures, where laboratory models suggest they modulate cellular ion transport, support intracellular calcium influx, and influence inflammatory signaling pathways.
  
• Photobiomodulation / Class IV Laser (MLS / LLLT): Continuous (808 nm) and superpulsed (905 nm) laser emissions are thought to be absorbed by cytochrome c oxidase within mitochondrial electron transport chains, boosting intracellular ATP production and suppressing pro-inflammatory cytokines (such as IL-1β and TNF-α).
  
• Hypertonic Dextrose Prolotherapy & Orthobiologics: Targeted intra- or peri-tendinous dextrose injections are intended to induce a localized osmotic stimulus, which is thought to trigger native growth factor release and support extracellular matrix collagen remodeling in degenerative tendon tissue.

Summary Research Table

Author(s) & Journal/Year	Study Objective & Design	Key Statistically Significant Outcomes
Rompe et al. American Journal of Sports Medicine (AJSM) (2009)	RCT (n=75) comparing eccentric loading alone vs. eccentric loading + radial ESWT in chronic midportion Achilles tendinopathy.	Combined eccentric loading + radial ESWT achieved an 82% success rate (VISA-A gain) at 4 months vs. 60% with eccentric loading alone (p = 0.002).
Rompe et al. The Journal of Bone and Joint Surgery (JBJS) (2008)	RCT (n=75) comparing radial ESWT to eccentric training and wait-and-see in chronic insertional Achilles tendinopathy.	Radial ESWT achieved a 64% success rate at 4 months compared to 28% for eccentric training and 24% for wait-and-see (p < 0.001).
Saxena et Al. Muscles, Ligaments and Tendons Journal (2019)	Prospective cohort study (n=24) assessing combined focused ESWT and radial soundwave therapy in Achilles tendinopathy.	VAS pain reduced from 6.3 ± 1.3 to 1.2 ± 1.6 (p = 0.00001); Roles and Maudsley score improved from 3.5 to 1.6 (p = 0.00001) at 17-month follow-up.
Robinson et al. The Journal of Foot & Ankle Surgery (2021)	Retrospective cohort study (n=87) comparing radial ESWT alone to combined radial + focused ESWT in Achilles tendinopathy.	MCID on VISA-A was met in 89.7% of patients treated with combined shockwave vs 63.8% with radial shockwave alone (p = 0.022).
Saxena et al. The Journal of Foot & Ankle Surgery (2011)	Prospective study (n=25) evaluating EPAT / radial soundwave therapy for Achilles tendinopathy.	75% overall success rate with statistically significant improvements in Roles and Maudsley scores and VAS pain at 1-year follow-up.
Gerdesmeyer et al. The Journal of Foot & Ankle Surgery (2017)	Prospective cohort study evaluating EMTT plus heel cushion vs. heel cushion alone over 12 weeks in Achilles tendinopathy.	Statistically significant superiority of EMTT + heel cushion in VAS pain reduction and Roles and Maudsley score improvements over heel cushion alone.
Naterstad et al. BMJ Open (2022)	Systematic review and meta-analysis of RCTs evaluating WALT-dosed laser photobiomodulation ± exercise in tendinopathy.	Laser added to exercise reduced tendon pain by -18.2 mm VAS (-13.2 mm alone), enhancing rehabilitation comfort and physical function.
Martimbianco et al. Clinical Rehabilitation (2020)	Systematic review and meta-analysis of 4 RCTs evaluating laser + eccentric loading in Achilles tendinopathy.	Clinically meaningful pain reduction of -2.55 VAS at 2 months exceeding the minimal clinically important difference.
Stergioulas et al. American Journal of Sports Medicine (AJSM) (2008)	RCT (n=52) evaluating LLLT (820 nm) + eccentric training in chronic Achilles tendinopathy.	Activity pain reduced to 33 mm in active laser group vs 53 mm in control at 12 weeks (p = 0.007).
Vignali L et al. Energy for Health (2017)	Descriptive clinical study evaluating dual-wave Class IV MLS laser in lower-extremity tendinopathies.	71.4% Achilles pain reduction (VAS 7.0 to 2.0) and 56.9% overall pain drop across anatomical sites.
Barreto ESR et al. Clinical Orthopaedics and Related Research (2025)	Meta-analysis of RCTs comparing autologous PRP vs. placebo in chronic Achilles tendinopathy.	Demonstrates no VISA-A functional or VAS pain benefit for PRP over placebo controls at 3, 6, or 12 months.
Kearney RS et al. JAMA (2021)	Multicenter RCT (n=240) evaluating single US-guided autologous PRP injection vs. sham in midportion Achilles tendinopathy.	VISA-A scores were 54.4 vs 53.4 at 6 months (p = ns; diff -2.7, 95% CI -8.8 to 3.3), demonstrating PRP is no more effective than sham injection.
Yelland MJ et al. British Journal of Sports Medicine (BJSM) (2011)	RCT (n=43) evaluating hypertonic dextrose prolotherapy + eccentric loading in Achilles tendinopathy.	DPT + eccentric loading achieved a +41.1 VISA-A functional score improvement at 12 months, superior to exercise alone.
Spector JE et al. Journal of the American Podiatric Medical Association (2021)	Retrospective case series (n=32) evaluating injectable mdHACM (AmnioFix) for chronic Achilles tendinopathy.	66% complete symptom resolution within 45 days post-injection in an uncontrolled clinical cohort.
Paoloni JA et al. British Journal of Sports Medicine (BJSM) (2019)	Systematic review evaluating topical nitroglycerin (glyceryl trinitrate) patches for noninsertional Achilles tendinopathy.	Early trials showed 78% symptom resolution vs 49% placebo, though recent meta-analyses demonstrate conflicting results without placebo superiority.